Jacobs Levy Equity Management, Inc Iovance Biotherapeutics, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q1 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,258,561 shares of IOVA stock, worth $2.81 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,258,561Holding current value
$2.81 Million% of portfolio
0.02%Shares
6 transactions
Others Institutions Holding IOVA
# of Institutions
318Shares Held
245MCall Options Held
1.39MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA25.1MShares$55.9 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$54.5 Million12.15% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$47.3 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$28.3 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$24.6 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $352M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...